{"id":81935,"date":"2025-07-21T16:47:00","date_gmt":"2025-07-21T16:47:00","guid":{"rendered":"https:\/\/www.cofb.org\/?p=81935"},"modified":"2025-07-22T10:57:37","modified_gmt":"2025-07-22T10:57:37","slug":"el-paper-de-la-farmacia-en-un-abordatge-360o-del-pacient-amb-obesitat","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2025\/07\/21\/el-paper-de-la-farmacia-en-un-abordatge-360o-del-pacient-amb-obesitat\/","title":{"rendered":"El paper de la farm\u00e0cia en un abordatge 360\u00ba del pacient amb obesitat"},"content":{"rendered":"\n

El passat 12 de juny, el Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB)<\/strong> va acollir la jornada formativa \u201cAbordatge 360\u00ba del pacient amb obesitat<\/strong>\u201d, amb el patrocini de Novo Nordisk<\/a>. La sessi\u00f3 va comptar amb la participaci\u00f3 d\u2019Andreea Ciudin<\/strong>, endocrin\u00f2loga i coordinadora de la Unitat de Tractament Integral de l\u2019Obesitat del Servei d\u2019Endocrinologia i Nutrici\u00f3 de l\u2019Hospital Universitari Vall d\u2019Hebron, Carla Morer<\/strong>, especialista en Medicina Familiar i Comunit\u00e0ria del CAP Rio de Janeiro (Barcelona), Violeta Moiz\u00e9<\/strong>, investigadora i nutricionista cl\u00ednica de la Unitat Funcional d\u2019Obesitat a l\u2019Hospital Cl\u00ednic de Barcelona, Felipe Isidro<\/strong>, llicenciat en Ci\u00e8ncies de l\u2019Activitat F\u00edsica i l\u2019Esport a l\u2019Universitat de Barcelona i Guille Pascual<\/strong>, farmac\u00e8utic i nutricionista comunitari a Farm\u00e0cia Marquina-Pascual. La formaci\u00f3 va ser moderada per Oscar Llans\u00f3<\/strong>, vocal d\u2019Administraci\u00f3 i Nutrici\u00f3 del COFB, i per Merc\u00e8 Barau<\/strong>, vocal d\u2019Oficina de Farm\u00e0cia del COFB.<\/p>\n\n\n\n

Els objectius de la formaci\u00f3<\/strong> van ser recon\u00e8ixer l\u2019obesitat com una malaltia cr\u00f2nica<\/strong>, con\u00e8ixer la seva fisiopatologia<\/strong>, aprofundir en les comorbiditats<\/strong>, revisar els tractaments actualment disponibles<\/strong> i les mesures higi\u00e8nic-diet\u00e8tiques indicades<\/strong>, entendre l\u2019impacte psicol\u00f2gic <\/strong>i fomentar el maneig integral i multidisciplinari dels pacients <\/strong>obesos.<\/p>\n\n\n\n

Falses creences i estigmatitzaci\u00f3 de l’obesitat<\/h2>\n\n\n\n

Andreea Ciudin <\/strong>va iniciar la presentaci\u00f3 afirmant que els farmac\u00e8utics <\/strong>\u201cs\u00f3n un col\u00b7lectiu que t\u00e9 molt de protagonisme <\/strong>i \u00e9s un bon aliat per fer les coses b\u00e9 en el tractament del pacient amb obesitat\u201d. Pel que fa als estudis sobre aquesta malaltia<\/strong>, \u201cfa 10 anys que es va comen\u00e7ar a dissenyar un canvi de paradigma en el tractament de l\u2019obesitat<\/strong>, a l\u2019Hospital Vall d\u2019Hebron, i s\u2019espera que aquesta llavor vagi arribant als diferents centres\u201d.<\/p>\n\n\n\n

\"Andreea<\/a>
Andreea Ciudin, en un moment de la seva presentaci\u00f3.<\/figcaption><\/figure>\n\n\n\n

Seguidament, va destacar que existeix entorn l\u2019obesitat<\/strong> \u201cmolta falsa creen\u00e7a<\/strong>, mites <\/strong>i estigmatitzaci\u00f3<\/strong>, i els primers que ho fan s\u00f3n els mateixos professionals<\/strong>\u201d. El primer pas per canviar el futur de la malaltia \u00e9s \u201ccomen\u00e7ar a utilitzar un llenguatge m\u00e9s adequat<\/strong>, demostrant que s\u2019ha ent\u00e8s la seva biologia. La malaltia<\/strong> est\u00e0 arribant a uns nivells de pand\u00e8mia<\/strong>\u201d.<\/p>\n\n\n\n

Com a membre de la Societat Espanyola d\u2019Obesitat<\/strong>, des de la instituci\u00f3 \u201ces defensa canviar la nomenclatura<\/strong>, passant-se a dir malaltia cr\u00f2nica adiposa<\/strong>\u201d. En aquest sentit, \u201cdir a alg\u00fa \u2018ob\u00e8s\u2019 estigmatitza i existeixen fenotips <\/strong>que provoquen que una persona, per molt que mengi b\u00e9, estigui en aquest estat<\/strong>\u201d.<\/p>\n\n\n\n

L’obesitat a l’Atenci\u00f3 Prim\u00e0ria<\/h2>\n\n\n\n

Agafant com a refer\u00e8ncia la \u201cGuia espanyola <\/strong>del maneig integral i multidisciplinari de l\u2019obesitat <\/strong>en persones adultes (GIRO)\u201d, Carla Morer <\/strong>va assegurar que l\u2019obesitat \u00e9s \u201cl\u2019arrel de m\u00faltiples malalties<\/strong>, arribant fins i tot a generar un impacte sist\u00e8mic m\u00e9s enll\u00e0 del pes. Aquesta malaltia \u00e9s la m\u00e9s coneguda i ocupa el nostre dia a dia a Atenci\u00f3 Prim\u00e0ria\u201d.<\/p>\n\n\n\n

A m\u00e9s, va explicar que en\u00a0les actuals consultes d\u2019Atenci\u00f3 Prim\u00e0ria\u00a0<\/strong>\u201cs\u2019han incorporat\u00a0screenings<\/em>\u00a0de la malaltia metab\u00f2lica del fetge gras.<\/strong>\u00a0L\u2019obesitat\u00a0<\/strong>per se<\/em>\u00a0incrementa el\u00a0risc,\u00a0<\/strong>i l\u2019adipositat\u00a0<\/strong>augmenta enormement el\u00a0risc coronari<\/strong>\u201d. Per altra banda, \u201cdurant el diagn\u00f2stic es pot tenir a un pacient metab\u00f2licament sa, per\u00f2 en el transcurs de la seva vida la malaltia cardiovascular augmenta molt el seu risc d\u2019apar\u00e8ixer\u201d.<\/p>\n\n\n\n

\"Carla<\/a>
Carla Morer va parlar sobre la visi\u00f3 d’Atenci\u00f3 Prim\u00e0ria pel que fa a l’obesitat.<\/figcaption><\/figure>\n\n\n\n

Finalment, l\u2019especialista en Medicina Familiar i Comunit\u00e0ria va indicar que el 60% de les morts<\/strong> en persones amb sobrep\u00e8s \u201c\u00e9s atribu\u00efble a malalties cardiovasculars\u201d<\/strong>. \u201c\u00c9s l\u00f2gic, doncs, que sigui el dia a dia dins l\u2019Atenci\u00f3 Prim\u00e0ria, i per aix\u00f2 ha de ser el principal focus d\u2019atenci\u00f3\u201d, va explicar Morer.<\/p>\n\n\n\n

El pacient, al centre del proc\u00e9s<\/h2>\n\n\n\n

Violeta Moiz\u00e9<\/strong> va iniciar la seva exposici\u00f3 tenint molt present als farmac\u00e8utics<\/strong>: \u201cEs tracta d\u2019un p\u00fablic diferent i necessari<\/strong> que arriba a oferir una visi\u00f3 general sobre l\u2019impacte psicosocial de l\u2019obesitat<\/strong>, centrant-nos en l\u2019estigma\u201d.<\/p>\n\n\n\n

A partir de la necessitat de con\u00e8ixer millor al malalt, \u201cel Cl\u00ednic va desenvolupar una unitat d\u2019intercanvi d\u2019experi\u00e8ncia del pacient\u201d. <\/strong>Va indicar que \u201cdes d\u2019aquesta consulta, <\/strong>es va aprofitar per aprendre m\u00e9s, provocant que els professionals es replantegin algunes estrat\u00e8gies<\/strong>. Va costar 25 anys adonar-nos que la mirada no era completa\u201d.<\/p>\n\n\n\n

\"Violeta<\/a>
Violeta Moiz\u00e9 va compartir l\u2019abordatge de l\u2019obesitat a l\u2019Hospital Cl\u00ednic a la seva xerrada.<\/figcaption><\/figure>\n\n\n\n

El\u00a0tractament del professional<\/strong>\u00a0\u201cha de passar per col\u00b7locar al pacient al centre del proc\u00e9s\u201d<\/strong>. Aquesta evoluci\u00f3 \u201cs\u2019ha de centrar en la persona, tal com es remarca en les\u00a0\u00faltimes guies cl\u00edniques canadenques<\/strong>, que estan marcant\u00a0un canvi de paradigma<\/strong>\u201d, va afirmar.<\/p>\n\n\n\n

Diferents tipus d\u2019obesitat, diferents recomanacions<\/h2>\n\n\n\n

El tractament del pacient amb obesitat tamb\u00e9 va ser analitzat per\u00a0Felipe Isidro<\/strong>, explicant que \u201cno es poden perpetuar les mateixes recomanacions<\/strong>\u00a0a\u00a0tots els pacients<\/strong>\u00a0amb aquesta malaltia, que compta amb una gran diversitat de tipologies\u201d. Per dur a terme una millor ter\u00e0pia, \u201cel professional ha d\u2019esbrinar\u00a0a quina persona es t\u00e9 al davant<\/strong>, no nom\u00e9s amb proves, sin\u00f3 tamb\u00e9 amb preguntes\u201d.<\/p>\n\n\n\n

\"Felipe<\/a>
Felipe Isidro parlant dels diferents tipus d\u2019obesitat durant la seva exposici\u00f3.<\/figcaption><\/figure>\n\n\n\n

Pel que fa a la recomanaci\u00f3 d\u2019exercici f\u00edsic<\/strong>, \u201cs\u2019ha d\u2019atendre el pacient seriosament i no en s\u00e8rie<\/strong>\u201d. Per dur-ho a terme amb \u00e8xit, \u201cs\u2019ha de posar a la pell de la persona per entendre-la i intentar aportar estrat\u00e8gies a cada barrera<\/strong> que es trobi el pacient per no fer exercici<\/strong>. \u00c9s clau buscar les millores priorit\u00e0ries per avan\u00e7ar\u201d, va concloure.<\/p>\n\n\n\n

La farm\u00e0cia i el seu paper en l’obesitat<\/h2>\n\n\n\n

Pel que fa a l\u2019aportaci\u00f3 de l\u2019oficina de farm\u00e0cia <\/strong>en l\u2019abordatge del pacient amb obesitat, Guille Pascual <\/strong>va assegurar que \u201ces pot oferir consell farmac\u00e8utic<\/strong> i serveis assistencials<\/strong>, un tracte humanista,<\/strong> coordinaci\u00f3 sanit\u00e0ria<\/strong>, un consell alimentari i prescripci\u00f3 d\u2019activitat f\u00edsica <\/strong>i, finalment, educaci\u00f3 sanit\u00e0ria i formaci\u00f3 continuada<\/strong>\u201d.<\/p>\n\n\n\n

\"Guille<\/a>
Guille Pascual, durant el transcurs de la seva presentaci\u00f3.<\/figcaption><\/figure>\n\n\n\n

Oferir una\u00a0humanitzaci\u00f3 de l\u2019atenci\u00f3 sociosanit\u00e0ria <\/strong>va ser vist per Pascual com la millor manera \u201cd\u2019apropar-se al pacient i a tot el seu entorn familiar<\/strong>, centrant-se en les seves necessitats i prefer\u00e8ncies\u201d. Les propostes que va explicar en aquest camp van ser \u201cpromoure l\u2019\u00fas humanitzat de la telemedicina<\/strong>\u00a0a trav\u00e9s de l\u2019atenci\u00f3, el seguiment remot dels pacients utilitzant plataformes segures que permetin l\u2019enviament i la\u00a0revisi\u00f3 i ajustament del pla diet\u00e8tic i de l\u2019exercici proposat<\/strong>\u201d.<\/p>\n\n\n\n

Per acabar, va compartir altres alternatives com “realitzar\u00a0seminaris informatius<\/strong>\u00a0per professionals pel que fa al maneig \u00fatil de noves tecnologies i xarxes socials i\u00a0l\u2019establiment d\u2019un pla de comunicaci\u00f3\u00a0<\/strong>amb el pacient que viu amb obesitat i que visita la farm\u00e0cia de forma habitual\u201d.<\/p>\n\n\n\n

Amb el patrocini de:<\/strong><\/p>\n\n\n\n

\"\"<\/a><\/figure>\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

El passat 12 de juny, el Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) va acollir la jornada formativa \u201cAbordatge 360\u00ba del pacient amb obesitat\u201d, amb el patrocini de Novo Nordisk. La sessi\u00f3 va comptar amb la participaci\u00f3 d\u2019Andreea Ciudin, endocrin\u00f2loga i coordinadora de la Unitat de Tractament Integral de l\u2019Obesitat del Servei d\u2019Endocrinologia i […]<\/p>\n","protected":false},"author":10,"featured_media":82070,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,57],"tags":[4795,18,19,3411,5406,3043,53,70,2381,290],"class_list":["post-81935","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-mon-collegial","tag-abordatge-del-pacient","tag-cofb","tag-collegi-de-farmaceutics-de-barcelona","tag-consultes","tag-estigmatizacio","tag-exercici-fisic","tag-farmaceutics","tag-formacio","tag-obesitat","tag-pacient"],"yoast_head":"\nEl paper de la farm\u00e0cia en un abordatge 360\u00ba del pacient amb obesitat - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"description\" content=\"El COFB va organitzar la confer\u00e8ncia \u201cAbordatge 360\u00ba del pacient amb obesitat\u201d amb el patrocini de Novo Nordisk"\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cofb.org\/ca\/2025\/07\/21\/el-paper-de-la-farmacia-en-un-abordatge-360o-del-pacient-amb-obesitat\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"El paper de la farm\u00e0cia en un abordatge 360\u00ba del pacient amb obesitat - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El COFB va organitzar la confer\u00e8ncia \u201cAbordatge 360\u00ba del pacient amb obesitat\u201d amb el patrocini de Novo Nordisk"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cofb.org\/ca\/2025\/07\/21\/el-paper-de-la-farmacia-en-un-abordatge-360o-del-pacient-amb-obesitat\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-21T16:47:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-22T10:57:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/07\/COFB_360_OBESITAT_14072025_04-1-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1468\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Xavier Magraner\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"Xavier Magraner\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.cofb.org\/2025\/07\/21\/el-paper-de-la-farmacia-en-un-abordatge-360o-del-pacient-amb-obesitat\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/07\/21\/el-paper-de-la-farmacia-en-un-abordatge-360o-del-pacient-amb-obesitat\/\"},\"author\":{\"name\":\"Xavier Magraner\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/e46d741cfb92c985a083d163d8270ae4\"},\"headline\":\"El paper de la farm\u00e0cia en un abordatge 360\u00ba del pacient amb obesitat\",\"datePublished\":\"2025-07-21T16:47:00+00:00\",\"dateModified\":\"2025-07-22T10:57:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/07\/21\/el-paper-de-la-farmacia-en-un-abordatge-360o-del-pacient-amb-obesitat\/\"},\"wordCount\":1272,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/07\/21\/el-paper-de-la-farmacia-en-un-abordatge-360o-del-pacient-amb-obesitat\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/07\/COFB_360_OBESITAT_14072025_04-1-scaled.jpg\",\"keywords\":[\"abordatge del pacient\",\"COFB\",\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"consultes\",\"estigmatizaci\u00f3\",\"exercici f\u00edsic\",\"farmac\u00e8utics\",\"Formaci\u00f3\",\"obesitat\",\"pacient\"],\"articleSection\":[\"Destacats\",\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cofb.org\/2025\/07\/21\/el-paper-de-la-farmacia-en-un-abordatge-360o-del-pacient-amb-obesitat\/\",\"url\":\"https:\/\/www.cofb.org\/2025\/07\/21\/el-paper-de-la-farmacia-en-un-abordatge-360o-del-pacient-amb-obesitat\/\",\"name\":\"El paper de la farm\u00e0cia en un abordatge 360\u00ba del pacient amb obesitat - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/07\/21\/el-paper-de-la-farmacia-en-un-abordatge-360o-del-pacient-amb-obesitat\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/07\/21\/el-paper-de-la-farmacia-en-un-abordatge-360o-del-pacient-amb-obesitat\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/07\/COFB_360_OBESITAT_14072025_04-1-scaled.jpg\",\"datePublished\":\"2025-07-21T16:47:00+00:00\",\"dateModified\":\"2025-07-22T10:57:37+00:00\",\"description\":\"El COFB va organitzar la confer\u00e8ncia \u201cAbordatge 360\u00ba del pacient amb obesitat\u201d amb el patrocini de Novo Nordisk\\\"\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/07\/21\/el-paper-de-la-farmacia-en-un-abordatge-360o-del-pacient-amb-obesitat\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cofb.org\/2025\/07\/21\/el-paper-de-la-farmacia-en-un-abordatge-360o-del-pacient-amb-obesitat\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/2025\/07\/21\/el-paper-de-la-farmacia-en-un-abordatge-360o-del-pacient-amb-obesitat\/#primaryimage\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/07\/COFB_360_OBESITAT_14072025_04-1-scaled.jpg\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/07\/COFB_360_OBESITAT_14072025_04-1-scaled.jpg\",\"width\":2560,\"height\":1468},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cofb.org\/2025\/07\/21\/el-paper-de-la-farmacia-en-un-abordatge-360o-del-pacient-amb-obesitat\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"El paper de la farm\u00e0cia en un abordatge 360\u00ba del pacient amb obesitat\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/e46d741cfb92c985a083d163d8270ae4\",\"name\":\"Xavier Magraner\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/aa0d1d4df59f71f88eebd5796c5388ff41c58d83c5301eb6e1d65646a289c37d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/aa0d1d4df59f71f88eebd5796c5388ff41c58d83c5301eb6e1d65646a289c37d?s=96&d=mm&r=g\",\"caption\":\"Xavier Magraner\"},\"url\":\"https:\/\/www.cofb.org\/ca\/author\/xmagraner\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"El paper de la farm\u00e0cia en un abordatge 360\u00ba del pacient amb obesitat - Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"El COFB va organitzar la confer\u00e8ncia \u201cAbordatge 360\u00ba del pacient amb obesitat\u201d amb el patrocini de Novo Nordisk\"","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cofb.org\/ca\/2025\/07\/21\/el-paper-de-la-farmacia-en-un-abordatge-360o-del-pacient-amb-obesitat\/","og_locale":"ca_ES","og_type":"article","og_title":"El paper de la farm\u00e0cia en un abordatge 360\u00ba del pacient amb obesitat - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El COFB va organitzar la confer\u00e8ncia \u201cAbordatge 360\u00ba del pacient amb obesitat\u201d amb el patrocini de Novo Nordisk\"","og_url":"https:\/\/www.cofb.org\/ca\/2025\/07\/21\/el-paper-de-la-farmacia-en-un-abordatge-360o-del-pacient-amb-obesitat\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2025-07-21T16:47:00+00:00","article_modified_time":"2025-07-22T10:57:37+00:00","og_image":[{"width":2560,"height":1468,"url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/07\/COFB_360_OBESITAT_14072025_04-1-scaled.jpg","type":"image\/jpeg"}],"author":"Xavier Magraner","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"Xavier Magraner","Temps estimat de lectura":"8 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cofb.org\/2025\/07\/21\/el-paper-de-la-farmacia-en-un-abordatge-360o-del-pacient-amb-obesitat\/#article","isPartOf":{"@id":"https:\/\/www.cofb.org\/2025\/07\/21\/el-paper-de-la-farmacia-en-un-abordatge-360o-del-pacient-amb-obesitat\/"},"author":{"name":"Xavier Magraner","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/e46d741cfb92c985a083d163d8270ae4"},"headline":"El paper de la farm\u00e0cia en un abordatge 360\u00ba del pacient amb obesitat","datePublished":"2025-07-21T16:47:00+00:00","dateModified":"2025-07-22T10:57:37+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cofb.org\/2025\/07\/21\/el-paper-de-la-farmacia-en-un-abordatge-360o-del-pacient-amb-obesitat\/"},"wordCount":1272,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/www.cofb.org\/2025\/07\/21\/el-paper-de-la-farmacia-en-un-abordatge-360o-del-pacient-amb-obesitat\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/07\/COFB_360_OBESITAT_14072025_04-1-scaled.jpg","keywords":["abordatge del pacient","COFB","Col\u00b7legi de Farmac\u00e8utics de Barcelona","consultes","estigmatizaci\u00f3","exercici f\u00edsic","farmac\u00e8utics","Formaci\u00f3","obesitat","pacient"],"articleSection":["Destacats","M\u00f3n col\u00b7legial"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/www.cofb.org\/2025\/07\/21\/el-paper-de-la-farmacia-en-un-abordatge-360o-del-pacient-amb-obesitat\/","url":"https:\/\/www.cofb.org\/2025\/07\/21\/el-paper-de-la-farmacia-en-un-abordatge-360o-del-pacient-amb-obesitat\/","name":"El paper de la farm\u00e0cia en un abordatge 360\u00ba del pacient amb obesitat - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cofb.org\/2025\/07\/21\/el-paper-de-la-farmacia-en-un-abordatge-360o-del-pacient-amb-obesitat\/#primaryimage"},"image":{"@id":"https:\/\/www.cofb.org\/2025\/07\/21\/el-paper-de-la-farmacia-en-un-abordatge-360o-del-pacient-amb-obesitat\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/07\/COFB_360_OBESITAT_14072025_04-1-scaled.jpg","datePublished":"2025-07-21T16:47:00+00:00","dateModified":"2025-07-22T10:57:37+00:00","description":"El COFB va organitzar la confer\u00e8ncia \u201cAbordatge 360\u00ba del pacient amb obesitat\u201d amb el patrocini de Novo Nordisk\"","breadcrumb":{"@id":"https:\/\/www.cofb.org\/2025\/07\/21\/el-paper-de-la-farmacia-en-un-abordatge-360o-del-pacient-amb-obesitat\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cofb.org\/2025\/07\/21\/el-paper-de-la-farmacia-en-un-abordatge-360o-del-pacient-amb-obesitat\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/2025\/07\/21\/el-paper-de-la-farmacia-en-un-abordatge-360o-del-pacient-amb-obesitat\/#primaryimage","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/07\/COFB_360_OBESITAT_14072025_04-1-scaled.jpg","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/07\/COFB_360_OBESITAT_14072025_04-1-scaled.jpg","width":2560,"height":1468},{"@type":"BreadcrumbList","@id":"https:\/\/www.cofb.org\/2025\/07\/21\/el-paper-de-la-farmacia-en-un-abordatge-360o-del-pacient-amb-obesitat\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"El paper de la farm\u00e0cia en un abordatge 360\u00ba del pacient amb obesitat"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/e46d741cfb92c985a083d163d8270ae4","name":"Xavier Magraner","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/aa0d1d4df59f71f88eebd5796c5388ff41c58d83c5301eb6e1d65646a289c37d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/aa0d1d4df59f71f88eebd5796c5388ff41c58d83c5301eb6e1d65646a289c37d?s=96&d=mm&r=g","caption":"Xavier Magraner"},"url":"https:\/\/www.cofb.org\/ca\/author\/xmagraner\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/07\/COFB_360_OBESITAT_14072025_04-1-scaled.jpg",2560,1468,false],"thumbnail":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/07\/COFB_360_OBESITAT_14072025_04-1-150x150.jpg",150,150,true],"medium":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/07\/COFB_360_OBESITAT_14072025_04-1-300x172.jpg",300,172,true],"medium_large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/07\/COFB_360_OBESITAT_14072025_04-1-768x440.jpg",768,440,true],"large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/07\/COFB_360_OBESITAT_14072025_04-1-1024x587.jpg",1024,587,true],"1536x1536":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/07\/COFB_360_OBESITAT_14072025_04-1-1536x881.jpg",1536,881,true],"2048x2048":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/07\/COFB_360_OBESITAT_14072025_04-1-2048x1174.jpg",2048,1174,true],"trp-custom-language-flag":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/07\/COFB_360_OBESITAT_14072025_04-1-18x10.jpg",18,10,true]},"uagb_author_info":{"display_name":"Xavier Magraner","author_link":"https:\/\/www.cofb.org\/ca\/author\/xmagraner\/"},"uagb_comment_info":0,"uagb_excerpt":"El passat 12 de juny, el Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) va acollir la jornada formativa \u201cAbordatge 360\u00ba del pacient amb obesitat\u201d, amb el patrocini de Novo Nordisk. La sessi\u00f3 va comptar amb la participaci\u00f3 d\u2019Andreea Ciudin, endocrin\u00f2loga i coordinadora de la Unitat de Tractament Integral de l\u2019Obesitat del Servei d\u2019Endocrinologia i […]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/81935","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=81935"}],"version-history":[{"count":28,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/81935\/revisions"}],"predecessor-version":[{"id":82078,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/81935\/revisions\/82078"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media\/82070"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=81935"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=81935"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=81935"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}